Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD008901Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 diciembre 2010see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Vidhu Thaker

    Correspondencia a: Haverstraw Pediatrics, Haverstraw, USA

    [email protected]

  • Alexandra L Haagensen

    Children's Hospital Boston, Boston, USA

  • Vanitha A Jagannath

    Department of Paediatrics, KIMS Bahrain Medical Center, Manama, Bahrain

  • Zbys Fedorowicz

    UKCC (Bahrain Branch), Ministry of Health, Bahrain, Awali, Bahrain

  • Brian W Houston

    School of Health & Social Care, Teesside University, Middlesbrough, UK

Contributions of authors

Roles and responsibilities

TASK

AUTHOR

Protocol stage: draft the protocol

VT, VJ, AH, BH

Review stage: select which trials to include (2 + 1 arbiter)

VT, VJ, BH

Review stage: extract data from trials (2 people)

VT, BH

Review stage: enter data into RevMan

VT, BH

Review stage: carry out the analysis

VT, BH

Review stage: interpret the analysis

VT, VJ, BH, ZF

Review stage: draft the final review

VT,VJ, AH, BH, ZF

Update stage: update the review

VT, VJ, AH, BH, ZF

Declarations of interest

There are no financial conflicts of interest and the authors declare that they do not have any associations with any parties who may have vested interests in the results of this review.

Acknowledgements

The authors would like to thank Nikki Jahnke of the Cochrane Cystic Fibrosis and Genetic Disorders Group for her support throughout the development of this protocol.

Version history

Published

Title

Stage

Authors

Version

2021 Aug 23

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Review

Vidhu Thaker, Ben Carter, Melissa Putman

https://doi.org/10.1002/14651858.CD008901.pub5

2018 Dec 17

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Review

Vidhu Thaker, Ben Carter, Melissa Putman

https://doi.org/10.1002/14651858.CD008901.pub4

2015 May 20

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Review

Vidhu Thaker, Alexandra L Haagensen, Ben Carter, Zbys Fedorowicz, Brian W Houston

https://doi.org/10.1002/14651858.CD008901.pub3

2013 Jun 05

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Review

Vidhu Thaker, Alexandra L Haagensen, Ben Carter, Zbys Fedorowicz, Brian W Houston

https://doi.org/10.1002/14651858.CD008901.pub2

2010 Dec 08

Recombinant growth hormone therapy for cystic fibrosis in children and young adults

Protocol

Vidhu Thaker, Alexandra L Haagensen, Vanitha A Jagannath, Zbys Fedorowicz, Brian W Houston

https://doi.org/10.1002/14651858.CD008901

Keywords

MeSH

Medical Subject Headings Check Words

Adolescent; Adult; Child; Child, Preschool; Humans; Young Adult;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.